JR

Juan Romero

Senior Director, Supply Chain International

Blueprint Medicines

Blueprint Medicines Pipeline

DrugIndicationPhase
AYVAKIT (avapritinib)Indolent Systemic MastocytosisApproved
Elenestinib (BLU-263)Indolent Systemic MastocytosisPhase 3
BLU-808Chronic Spontaneous & Inducible UrticariaPlanned